Challenge
The application related to a peripheral vascular stent. The USPTO issued a non-final Office Action dated July 18, 2025, raising Section 112(b) indefiniteness issues and Section 103 obviousness rejections over Kariniemi in view of Cheng.
The core difficulty was not only to respond to prior art, but also to make the claim structure precise enough for U.S. examination while preserving commercially meaningful protection for the stent design.
Strategy
- Rebuilt the independent claim around concrete structural limitations rather than broad functional language.
- Focused the argument on a stent architecture using sinusoidal rings connected solely by a membrane, without metal connections between adjacent rings.
- Clarified the claimed opening pattern and staggered ring arrangement so that the examiner could evaluate the invention against the cited references on specific structural terms.
- Handled the evidentiary record carefully after the examiner considered, but did not find sufficient, a Rule 1.132 declaration.
Result
The USPTO issued a Notice of Allowance on May 1, 2026. The examiner’s reasons for allowance recognized that the prior art did not teach or render obvious the claimed membrane-only connection structure, opening pattern, and staggered sinusoidal ring arrangement in combination with the other claim elements.